The Stop TB Partnership Secretariat is pleased to extend the closing date of this year's Kochon Prize call for nomination until Friday, 24 July.

Millions of people in developing countries could be affected if India caves in to pressure.

The consultation process is open to everyone to share information, ideas and experiences, and, will run from 10 June to 10 August 2015.

If 8% of persons with latent tuberculosis could be permanently protected each year, the global TB incidence in 2050 would be 14 times lower as the incidence in 2013, with no other intervention needed.

This year, the Kochon Foundation Prize is ensuring that we recognize the great heroes who go above and beyond each day – the countless people (health workers, community workers and volunteers) who have made an enormous impact by saving lives.

The guide focuses on issues of importance to nurses and the types of care they provide to individuals with drug-resistant TB.

First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB.

The report provides a high-level assessment of the development pipeline for new antibiotics, and sets out the Review’s initial proposals for the action needed at a global level to kick-start antibiotic drug discovery efforts.

Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.

The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.